Awakn Life Sciences Corp. (OTCMKTS:AWKNF) Short Interest Update

Awakn Life Sciences Corp. (OTCMKTS:AWKNF) was the recipient of a significant drop in short interest in March. As of March 31st, there was short interest totalling 1,000 shares, a drop of 9.1% from the March 15th total of 1,100 shares. Based on an average daily volume of 15,900 shares, the days-to-cover ratio is currently 0.1 days.

Awakn Life Sciences Stock Down 15.6 %

Awakn Life Sciences stock opened at $0.14 on Monday. The business has a 50 day moving average of $0.10 and a 200-day moving average of $0.12. Awakn Life Sciences has a 1 year low of $0.04 and a 1 year high of $0.36.

Awakn Life Sciences Company Profile

Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD.